Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Magicbuvir vs Sovaldi (Sofosbuvir) in Healthy Volunteers
NCT02953535Phase 1Completed
- Sponsor
- Genuine Research Center
- Start
- May 2016
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of sofosbuvir in hepatitis C (HCV) (2 arms), sponsored by Genuine Research Center. Primary endpoints: Maximal measured plasma concentration, Area under the plasma concentration-time curve from time zero to the last measurable concentration and 1 more. Started May 2016; status: completed.
02
Drugs
sofosbuvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT02953535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02953535.